Inozyme Pharma Inc.

NASDAQ: INZY · Real-Time Price · USD
4.00
0.00 (0.00%)
At close: Jun 30, 2025, 3:59 PM

Inozyme Pharma Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-1.71 -3.1 -0.61 -2.85
PEG Ratio
-0.09 0.15 0.02 n/a
PS Ratio
n/a n/a n/a n/a
PB Ratio
3.01 1.57 0.33 1.47
P/FCF Ratio
-1.89 -3.11 -0.68 -3.31
P/OCF Ratio
-1.89 -3.12 -0.69 -3.34
OCF/S Ratio
n/a n/a n/a n/a
Debt / Equity Ratio
0.81 0.33 0.06 0.03
Quick Ratio
3.56 13.36 8.94 9.92
Current Ratio
3.56 13.36 8.93 9.92
Asset Turnover
n/a n/a n/a n/a
Interest Coverage
18.72 -22.7 n/a n/a
Return on Equity
-1.76 -0.51 -0.55 -0.52
Return on Assets
-0.83 -0.35 -0.47 -0.46
Return on Invested Capital
-0.99 -0.4 -0.53 -0.5
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a n/a n/a
Net Profit Margin
n/a n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a n/a
Operating Profit Margin
n/a n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a n/a n/a